These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7687766)

  • 1. [Treatment of chronic myeloid leukemia].
    Guilhot F
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):151-4. PubMed ID: 7687766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia].
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Senatore M
    Haematologica; 1990; 75 Suppl 4():33-40. PubMed ID: 1705912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of chronic myeloid leukemia].
    Freund M
    Internist (Berl); 1993 Jun; 34(6):542-9. PubMed ID: 8335444
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment].
    Reiffers J; Montastruc M; Bilhou-Nabera C
    Rev Prat; 1990 Sep; 40(20):1879-85. PubMed ID: 1699264
    [No Abstract]   [Full Text] [Related]  

  • 5. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation for chronic myeloid leukaemia.
    Goldman JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic myelogenous leukemia: a review and update of therapeutic strategies.
    Garcia-Manero G; Faderl S; O'Brien S; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 2003 Aug; 98(3):437-57. PubMed ID: 12879460
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosine kinase inhibitors in chronic myeloid leukemia.
    Sawyers CL; Druker B
    Cancer J Sci Am; 1999; 5(2):63-9. PubMed ID: 10198725
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of chronic myelogenous leukemia].
    Shibata A; Hashimoto S
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1053-9. PubMed ID: 1383365
    [No Abstract]   [Full Text] [Related]  

  • 10. Gancyclovir-induced megakaryocyte loss in chronic myelogenous leukemia post bone-marrow transplant.
    Gardner L; Grosso LE
    Am J Hematol; 1996 Nov; 53(3):204-5. PubMed ID: 8895696
    [No Abstract]   [Full Text] [Related]  

  • 11. Autotransplantation for chronic myeloid leukemia: is it useful?
    Olavarria E
    Haematologica; 2002 Jan; 87(1):3-6. PubMed ID: 11801458
    [No Abstract]   [Full Text] [Related]  

  • 12. NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
    Berman E; Clift RA; Copelan EA; Emanuel PD; Erba HP; Glenn MJ; Greenberg PL; Jones RJ; O'Brien S; Saba HI; Schilder R; Snyder DS; Soiffer RJ; Tallman MS; Wetzler M; Ravandi-Kashani F; Kantarjian H; Talpaz M;
    Oncology (Williston Park); 2000 Nov; 14(11A):229-40. PubMed ID: 11195415
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advancements in the treatment of chronic myelogenous leukemia.
    O'Dwyer ME; Mauro MJ; Druker BJ
    Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia--update and future directions.
    Kantarjian HM; Deisseroth A; Talpaz M
    Rev Invest Clin; 1994 Apr; Suppl():118-24. PubMed ID: 7886295
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic myeloid leukemia.
    Singhal N; Bapsy PP; Babu KG; George J
    J Assoc Physicians India; 2004 May; 52():410-6. PubMed ID: 15656033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon-alpha therapy in chronic myelogenous leukemia].
    Ohnishi K
    Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment of chronic myelogenous leukemia.
    Goldman JM
    Pathol Biol (Paris); 1989 Feb; 37(2):128-9. PubMed ID: 2469054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 20. An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr.
    Polák J; Koza V; Cetkovský P; Haskovec C
    Bone Marrow Transplant; 2000 May; 25(10):1109-10. PubMed ID: 10828875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.